MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-219.85M
↓ 147% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-88.99M
Historical baseline
PeriodValueYoY Change
2025$-219.85M-55.1%
2024$-141.71M-163.6%
2023$-53.75M+17.2%
2022$-64.90M-21.0%
2021$-53.63M-58943.5%
2020$-90838.00-